Detalhe da pesquisa
1.
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
J Virol
; 96(17): e0011822, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972290
2.
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection.
PLoS Pathog
; 17(9): e1009897, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34492082
3.
A gossypol derivative effectively protects against Zika and dengue virus infection without toxicity.
BMC Biol
; 20(1): 143, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35706035
4.
Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
Biophys J
; 120(6): 1011-1019, 2021 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33607086
5.
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
J Virol
; 94(5)2020 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826992
6.
Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
J Virol
; 93(17)2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189716
7.
Cryo-Electron Microscopy Structure of Porcine Deltacoronavirus Spike Protein in the Prefusion State
J Virol
; 92(4)2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29070693
8.
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
J Virol
; 92(18)2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29950421
9.
Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
J Virol
; 91(1)2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27795425
10.
A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodies.
JCI Insight
; 9(5)2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456504
11.
MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
Virus Res
; 334: 199156, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336390
12.
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants.
Nat Commun
; 14(1): 2962, 2023 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221158
13.
Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants.
Nat Commun
; 14(1): 2179, 2023 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37069158
14.
Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates.
Sci Adv
; 9(24): eadg3277, 2023 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315135
15.
A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection.
Nat Commun
; 14(1): 8042, 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052844
16.
Advances in mRNA and other vaccines against MERS-CoV.
Transl Res
; 242: 20-37, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34801748
17.
RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.
Transl Res
; 248: 11-21, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489692
18.
Re-burying Artificially Exposed Surface of Viral Subunit Vaccines Through Oligomerization Enhances Vaccine Efficacy.
Front Cell Infect Microbiol
; 12: 927674, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846760
19.
Infection and chronic disease activate a brain-muscle signaling axis that regulates muscle performance.
bioRxiv
; 2022 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33398283
20.
A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry.
mBio
; 13(4): e0148522, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35862773